Organovo Holdings, Inc. (ONVO) Financials

ONVO Assets vs Liabilities

DateAssetsLiabilities
Dec. 31, 2024 3.8 million 3.5 million
Sept. 30, 2024 6.8 million 3.1 million
June 30, 2024 9.5 million 2.8 million
March 31, 2024 6.3 million 2.7 million

ONVO Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Dec. 31, 2024 -1.8 million 130000
Sept. 30, 2024 -2.7 million 155000
June 30, 2024 -3.0 million 156000
March 31, 2024 -2.7 million 201000

ONVO Net Income

No data available :(

ONVO Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Dec. 31, 2024 1.2 million 543000 -
Sept. 30, 2024 3.2 million 660000 1.2 million
June 30, 2024 6.2 million 775000 1.3 million
March 31, 2024 2.9 million 888000 1.4 million

ONVO Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Dec. 31, 2024 ?
Sept. 30, 2024 18.0 million
June 30, 2024 14.7 million
March 31, 2024 10.1 million

ONVO Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Dec. 31, 2024 - 1.8 million 1.7 million -
Sept. 30, 2024 13000 984000 1.7 million 12000
June 30, 2024 - 1.3 million 2.0 million -1
March 31, 2024 - 1.0 million 2.0 million -1

ONVO Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Dec. 31, 2024 24000 2000
Sept. 30, 2024 30000 1000
June 30, 2024 39000 72000
March 31, 2024 29000 70000

ONVO Revenue by Segment

Graph available only for paid members. Upgrade to see it.

ONVO

Price: $2.04

52 week price:
1.66
21.96

Earnings Per Share: -10.08 USD

P/E Ratio: -0.22

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 21800

Ebitda: -7.6 million

Market Capitalization: 3.7 million

Links: